Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Captopril for prevention of hand-foot syndrome in colon cancer patients
IRCT20130311012782N50Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of captopril in colorectal cancer (CRC) and Erythrodysesthesia syndrome (PPE), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Incidence of hand-foot syndrome. Started Apr 2021; status: completed.
02
Drugs
captopril
03
Conditions
colorectal cancer (CRC)Erythrodysesthesia syndrome (PPE)
Beyond the preview
Go deeper on IRCT20130311012782N50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130311012782N50.